Cargando…

Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids

Type 2 diabetes mellitus confers a threefold increased risk for tuberculosis, but the underlying immunological mechanisms are still largely unknown. Possible mediators of this increased susceptibility are short-chain fatty acids, levels of which have been shown to be altered in individuals with diab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lachmandas, Ekta, van den Heuvel, Corina N. A. M., Damen, Michelle S. M. A., Cleophas, Maartje C. P., Netea, Mihai G., van Crevel, Reinout
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709651/ https://www.ncbi.nlm.nih.gov/pubmed/27057552 http://dx.doi.org/10.1155/2016/6014631

Ejemplares similares

The Effect of Hyperglycaemia on In Vitro Cytokine Production and Macrophage Infection with Mycobacterium tuberculosis
por: Lachmandas, Ekta, et al.
Publicado: (2015)

Patients with type 1 diabetes mellitus have impaired IL-1β production in response to Mycobacterium tuberculosis
por: Lachmandas, E., et al.
Publicado: (2017)

Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects
por: Lachmandas, Ekta, et al.
Publicado: (2019)

Assessing the effect of BCG revaccination on long-term mortality
por: Netea, Mihai G, et al.
Publicado: (2021)

Tissue Metabolic Changes Drive Cytokine Responses to Mycobacterium tuberculosis
por: Lachmandas, Ekta, et al.
Publicado: (2018)

Innate Immune Recognition of Mycobacterium tuberculosis
por: Kleinnijenhuis, Johanneke, et al.
Publicado: (2011)

Polymorphisms in Autophagy Genes and Susceptibility to Tuberculosis
por: Songane, Mario, et al.
Publicado: (2012)

Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibility
por: Ssekamatte, Phillip, et al.
Publicado: (2023)

Designing the Next Generation of Vaccines: Relevance for Future Pandemics
por: Domínguez-Andrés, Jorge, et al.
Publicado: (2020)

Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells
por: Lachmandas, Ekta, et al.
Publicado: (2016)

Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
por: Netea, Mihai G., et al.
Publicado: (2020)

The Interaction of Diabetes and Tuberculosis: Translating Research to Policy and Practice
por: van Crevel, Reinout, et al.
Publicado: (2021)

Immunometabolic Pathways in BCG-Induced Trained Immunity
por: Arts, Rob J.W., et al.
Publicado: (2016)

β-Glucan Induces Protective Trained Immunity against Mycobacterium tuberculosis Infection: A Key Role for IL-1
por: Moorlag, Simone J.C.F.M., et al.
Publicado: (2020)

Effects of Liver Resection on Hepatic Short-Chain Fatty Acid Metabolism in Humans
por: Neis, Evelien P. J. G., et al.
Publicado: (2016)

Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits
por: Böhme, Julia, et al.
Publicado: (2020)

Natural resistance against infections: focus on COVID-19
por: Netea, Mihai G., et al.
Publicado: (2022)

A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians
por: Png, Eileen, et al.
Publicado: (2012)

Differential effects of BCG vaccine on immune responses induced by vi polysaccharide typhoid fever vaccination: an explorative randomized trial
por: Blok, Bastiaan A., et al.
Publicado: (2020)

NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis
por: Ferwerda, Gerben, et al.
Publicado: (2005)

Heroin Use Is Associated with Suppressed Pro-Inflammatory Cytokine Response after LPS Exposure in HIV-Infected Individuals
por: Meijerink, Hinta, et al.
Publicado: (2015)

Closing the Policy-Practice Gap in the Management of Child Contacts of Tuberculosis Cases in Developing Countries
por: Hill, Philip C., et al.
Publicado: (2011)

The Correlation of Short-Chain Fatty Acids with Peripheral Arterial Disease in Diabetes Mellitus Patients
por: Muradi, Akhmadu, et al.
Publicado: (2022)

Long-term treated HIV infection is associated with platelet mitochondrial dysfunction
por: van der Heijden, Wouter A., et al.
Publicado: (2021)

Modulation of Adipocyte Metabolism by Microbial Short-Chain Fatty Acids
por: May, Karolline S., et al.
Publicado: (2021)

Implementation of LED Fluorescence Microscopy for Diagnosis of Pulmonary and HIV-Associated Tuberculosis in a Hospital Setting in Indonesia
por: Chaidir, Lidya, et al.
Publicado: (2013)

Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus
por: Tang, Ruiqi, et al.
Publicado: (2021)

Short-Chain Fatty Acids as Bacterial Enterocytes and Therapeutic Target in Diabetes Mellitus Type 2
por: Neag, Maria-Adriana, et al.
Publicado: (2022)

Linking minimum inhibitory concentrations to whole genome sequence-predicted drug resistance in Mycobacterium tuberculosis strains from Romania
por: Ruesen, Carolien, et al.
Publicado: (2018)

Short-chain fatty acids in diseases
por: Zhang, Dan, et al.
Publicado: (2023)

Routine vaccination for influenza and pneumococcal disease and its effect on COVID-19 in a population of Dutch older adults
por: Taks, Esther J.M., et al.
Publicado: (2023)

High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre
por: Seijger, Charlotte, et al.
Publicado: (2019)

Active and latent tuberculosis among HIV-positive injecting drug users in Indonesia
por: Meijerink, Hinta, et al.
Publicado: (2015)

The Divergent Immunomodulatory Effects of Short Chain Fatty Acids and Medium Chain Fatty Acids
por: Sam, Qi Hui, et al.
Publicado: (2021)

Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus
por: Tsai, Hui-Ju, et al.
Publicado: (2023)

The Cording Phenotype of Mycobacterium tuberculosis Induces the Formation of Extracellular Traps in Human Macrophages
por: Kalsum, Sadaf, et al.
Publicado: (2017)

Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?
por: Becker, Anouck, et al.
Publicado: (2021)

Corrigendum to “Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus”
por: Tang, Ruiqi, et al.
Publicado: (2021)

Composition of Maternal Circulating Short-Chain Fatty Acids in Gestational Diabetes Mellitus and Their Associations with Placental Metabolism
por: Wang, Shuxian, et al.
Publicado: (2022)

Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids
por: YAMAMURA, Ryodai, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0lgoqi681d4p524jaj4m6m8qqu